Civilization Ventures
San Francisco, California, United StatesFounded 2017
Civilization Ventures is a San Francisco-based venture capital firm that focuses entirely on early-stage biology and healthcare companies. Their investment strategy emphasizes digital health, diagnostics, gene therapy, genomics, synthetic biology, and AI applied to biotech, while also providing "mentor capital" and support to founders.
50% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (2 deals in the last 12 months vs 4 prior). Average disclosed round size is $54.6M (across 17 rounds with reported amounts).
Portfolio
18
Fund Size
$200M
Top Stage
Series A
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
18 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Iantrek, Inc. | Series C | $42M | Aug 2025 |
 Antheia | Series C | $56M | Jun 2025 |
| NNanite | Unknown | — | Feb 2025 |
| OOxford Cancer Analytics (OXcan) | Series A | $11M | Jan 2025 |
 Outpace Bio | Series B | $144M | Aug 2024 |
 BillionToOne | Series D | $130M | Jun 2024 |
 Foresight Diagnostics | Series B | $58.8M | Apr 2023 |
 Wyndly | Seed | $2M | Feb 2023 |
 Kernal Biologics, Inc. | Series A | $25M | Jul 2022 |
| BillionToOne | Series C | $125M | Mar 2022 |
 Omada Health | Series E | $192M | Feb 2022 |
 Glyphic Biotechnologies | Seed | $6.0M | Jul 2021 |
| Foresight Diagnostics | Series A | $12.5M | Jun 2021 |
| BillionToOne | Series A | $15M | Mar 2020 |
| Omada Health | Series C | $73M | Jun 2019 |
| BillionToOne | Series A | $15M | Mar 2019 |
 Fluent BioSciences | Series A | $19M | — |
 adyn | Seed | $2.5M | — |
Top Co-Investors
Hummingbird Ventures5 shared
Y Combinator4 shared
Neotribe3 shared
Libertus3 shared
HOF Capital2 shared
U.S. Venture Partners2 shared
aMoon2 shared
Pacific 8 Ventures2 shared
Wellington Management2 shared
Norwest Venture Partners2 shared
Baillie Gifford2 shared
Adams Street2 shared
Bluebird Ventures2 shared
Pear VC2 shared
EDBI1 shared
Viking Global Investors1 shared
In-Q-Tel1 shared
Illumina Ventures1 shared
Samsara BioCapital1 shared
Osage University Partners1 shared
Last updated: 12 April 2026